Form D Explorer
Biolinq Inc · CIK 1685406

Report a data issueCitable research briefCompare issuerPrivate research collection

Biolinq Inc

CIK 1685406 · Corporation · Inc. DELAWARE · SAN DIEGO, California · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
1
Original notices
1
Amendments
0
Activity
Mar 21, 2025
through Mar 21, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Mar 21, 2025

Reported offering amount
$100,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$90,000,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (1)